SE405806B - Forfarande for framstellning av urokinas-heparinkomplex - Google Patents

Forfarande for framstellning av urokinas-heparinkomplex

Info

Publication number
SE405806B
SE405806B SE7212220A SE1222072A SE405806B SE 405806 B SE405806 B SE 405806B SE 7212220 A SE7212220 A SE 7212220A SE 1222072 A SE1222072 A SE 1222072A SE 405806 B SE405806 B SE 405806B
Authority
SE
Sweden
Prior art keywords
urokinase
heparin
solution
complex
urokinas
Prior art date
Application number
SE7212220A
Other languages
English (en)
Swedish (sv)
Inventor
E G Vairel
J Goulay
J Choay
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7134435A external-priority patent/FR2153200A1/fr
Priority claimed from FR7223868A external-priority patent/FR2190413A2/fr
Priority claimed from FR7223867A external-priority patent/FR2190412A1/fr
Application filed by Choay Sa filed Critical Choay Sa
Publication of SE405806B publication Critical patent/SE405806B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SE7212220A 1971-09-24 1972-09-21 Forfarande for framstellning av urokinas-heparinkomplex SE405806B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR7134435A FR2153200A1 (en) 1971-09-24 1971-09-24 Stable,pyrogen-free urokinase prepns - from human urine
FR7223868A FR2190413A2 (en) 1972-06-30 1972-06-30 Stable,pyrogen-free urokinase prepns - from human urine
FR7223867A FR2190412A1 (en) 1972-06-30 1972-06-30 Stable,pyrogen-free urokinase prepns - from human urine

Publications (1)

Publication Number Publication Date
SE405806B true SE405806B (sv) 1979-01-08

Family

ID=27249660

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7212220A SE405806B (sv) 1971-09-24 1972-09-21 Forfarande for framstellning av urokinas-heparinkomplex
SE7514792A SE7514792L (sv) 1971-09-24 1975-12-30 Forfarande for framstellning av urokinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7514792A SE7514792L (sv) 1971-09-24 1975-12-30 Forfarande for framstellning av urokinas

Country Status (11)

Country Link
JP (1) JPS5718465B2 (fr)
BE (1) BE789189A (fr)
CA (1) CA986013A (fr)
CH (2) CH604726A5 (fr)
DE (1) DE2246969C2 (fr)
DK (1) DK133130C (fr)
ES (3) ES406980A1 (fr)
GB (2) GB1411422A (fr)
IN (1) IN141112B (fr)
NL (1) NL7212891A (fr)
SE (2) SE405806B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428248B2 (de) * 1973-07-24 1978-01-12 Serna Ag, Glarus (Schweiz) Verfahren zur herstellung von pyrogenfreier urokinase
US3957582A (en) * 1974-11-20 1976-05-18 Abbott Laboratories Purification of urokinase
JPS59143694U (ja) * 1983-03-14 1984-09-26 東洋電機製造株式会社 自動製図裁断機の押罫装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3256158A (en) * 1963-03-22 1966-06-14 Abbott Lab Purification of urokinase
US3355361A (en) * 1964-10-15 1967-11-28 Sterling Drug Inc Recovery and purification of urokinase
US3477912A (en) * 1967-07-07 1969-11-11 Century Lab Inc Method of production of urokinase
US3477913A (en) * 1967-10-31 1969-11-11 Century Lab Inc Method of production of urokinase

Also Published As

Publication number Publication date
CH560050A5 (fr) 1975-03-27
GB1411421A (en) 1975-10-22
BE789189A (fr) 1973-03-22
JPS4856888A (fr) 1973-08-09
DK133130B (da) 1976-03-29
ES440244A1 (es) 1977-08-01
ES406980A1 (es) 1976-06-16
DE2246969C2 (de) 1986-12-11
NL7212891A (fr) 1973-03-27
CH604726A5 (fr) 1978-09-15
JPS5718465B2 (fr) 1982-04-16
DK133130C (da) 1976-09-27
DE2246969A1 (de) 1973-04-05
SE7514792L (sv) 1975-12-30
ES455975A1 (es) 1978-03-01
GB1411422A (en) 1975-10-22
IN141112B (fr) 1977-01-22
CA986013A (en) 1976-03-23

Similar Documents

Publication Publication Date Title
Hirsh et al. Heparin kinetics in venous thrombosis and pulmonary embolism.
Gralnick et al. Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia
Thomas et al. Gold-Precipitation by Heparin of a Protein in Rabbit and Human Plasma
Rabiner et al. The role of intravascular haemolysis and the reticulo‐endothelial system in the production of a hypercoagulable state
Schipper et al. Antithrombin-III transfusion in disseminated intravascular coagulation
Lefer et al. Relationship of plasma peptides to the myocardial depressant factor in hemorrhagic shock in cats
White et al. Synergistic toxicity of endotoxin and hemoglobin
Bell et al. The effect of arvin on blood coagulation factors
Aikawa Effect of glucose and insulin on magnesium metabolism in rabbits. A study with Mg28.
FR2497229A1 (fr) Procede de preparation d'un derive polysaccharidique de fibrinolysine
NURMOHAMED et al. Long-term Efficacy and Safety of a Low Molecular Weight Heparin in Chronic Hemodialysis Patients A Comparison with Standard Heparin
JPH01500997A (ja) ヒアルロニダーゼの使用
JPS595164A (ja) 放射性コンプレツクス
US4106992A (en) Purification of urokinase
Weiss et al. Platelet factor 4 in platelet disorders–Storage location and the requirement of endogenous ADP for its release
SE405806B (sv) Forfarande for framstellning av urokinas-heparinkomplex
McCullough et al. Rapid plasma exchange with the continuous flow centrifuge
Gans Thrombogenic properties of epsilon amino caproic acid
EP0020780A1 (fr) Materiau fibrinolytique et son procede de fabrication
Canaud et al. Prostacyclin (epoprostenol) as the sole antithrombotic agent in postdilutional hemofiltration
JPH0454651B2 (fr)
CN101160133B (zh) 治疗用途的来自人血浆的内-α抑制剂蛋白质的制备和组合物
JPS61267524A (ja) フィブリン親和性ウロキナーゼ複合体含有血栓溶解剤
US20070275086A1 (en) Use of Increased Molecular-Weight Hirudin as an Anticoagulant in Extracorporeal Kidney Replace Therapy
US3639626A (en) Suppressing the activity of plasmin in humans and animals with trans-4-(aminomethyl)-cyclohexane - 1 - carboxylic acid